Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: Its therapeutic implication for MTAP (-) malignancies

Clinical Cancer Research

Volumn 3, Issue 3, 1997, Pages 433-438

  Yu, John ^a   Batova, Ayse ^b   Shao, Li En ^a   Carrera, Carlos J ^c   Yu, Alice L ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UCSD MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' DEOXYADENOSINE; ADENOSINE DERIVATIVE; ALANOSINE; PHOSPHORYLASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; DRUG TARGETING; ENZYME DEFICIENCY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEM CELL;

ALANINE; ANTIBIOTICS, ANTINEOPLASTIC; CELL DIVISION; COLONY-FORMING UNITS ASSAY; DEOXYADENOSINES; DRUG DESIGN; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, T-CELL, ACUTE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; PURINE-NUCLEOSIDE PHOSPHORYLASE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0030887270     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Fitchen, J. H.,Riscoe, M. K.,Dana, B. W.,Lawrence, H. J.,and Ferro, A. J. Methylthioadenosine phosphorylase deficiency in human leukemias and solid tumors. Cancer Res.,46:5409-5412, 1986.
2. Toohey, J. I. Methylthioadenosine nucleoside phosphorylase deficiency in methylthio-dependent cancer cells. Biochem. Biophys. Res. Commun.,83:27-35, 1978.
3. Kamatani, N.,Nelson-Rees, W. A.,and Carson, D. A. Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme. Proc. Natl. Acad. Sci. USA, 78:1219-1223, 1981.
4. Kamatani, N.,Yu, A. L.,and Carson, D. A. Deficiency of methyl-thioadenosine phosphorylase in human leukemic cells in vivo. Blood, 60:1387-1391, 1982.
5. Batova, A.,Diccianni, M. B.,Nobori, T.,Vu, T.,Yu, J.,Bridgeman, L.,and Yu, A. L. Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy. Blood, 88:3083-3090, 1996.
6. Nobori, T.,Szinai, I.,Amox, D.,Parker, B.,Olopade, O. I.,Buchhagen, D. L.,and Carson, D. A. Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers. Cancer Res.,53:1098-1101, 1993.
7. Traweek, S. T.,Riscoe, M. K.,Ferro, A. J.,Braziel, R. M.,Magenis, R. E.,and Ftchen, J. H. Methylthioadenosine phosphorylase deficiency in acute leukemia: pathologic, cytogenetic, and clinical features. Blood, 71:1568-1573, 1988.
8. Kubota, M.,Kamatani, N.,and Carson, D. A. Biochemical genetic analysis of the role of methylthioadenosine phosphorylase in a murine lymphoid cell line. J. Biol. Chem.,256: 7288-7291, 1983.
9. Christa, L.,Thuillier, L.,Munier, A.,and Perignon, J-L. Salvage of 5′-deoxy-methy]thioadenosine into purines and methionine by lymphoid cells and inhibition of cell proliferation. Biochim. Biophys. Acta, 803:7-10, 1984.
10. Kamatani, N.,and Carson, D. A. Abnormal regulation of methyl-thioadenosine and polyamine metabolism in methylthioadenosine phosphorylase-deficient human leukemic cell lines. Cancer Res.,40:178-182, 1980.
11. Lane, T. A.,Law, P.,Maruyama, M.,Young, D.,Burgess, J.,Mullen, M.,Mealiffe, M.,Terstappen, L. W. M. M.,Hardwick, A.,Moubayed, M.,Oldham, F.,Corringham, R. E. T.,and Ho, A. D. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood, 85:275-282, 1995.
12. Iscove, N. N.,Sieber, F.,and Winterhalter, K. H. Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J. Cell Physiol.,83:309-320, 1974.
13. McNiece, I. K.,Stewart, F. M.,Deacon, D. M.,Temeles, D. S.,Zsebo, K. M.,Clark, S. C.,and Quesenberry, P. J. Detection of a human CFC with a high proliferative potential. Blood, 74:609-612, 1989.
14. McNiece, I. K.,Bertoncello, I.,Kriegler, A. B.,and Quesenberry, P. J. Colony-forming cells with high proliferative potential (HPP-CFC). Int. J. Cell Cloning, 8:146-160, 1990.
15. Kamb, A.,Gruis, N. A.,Weaver-Feldhaus, J.,Lui, Q.,Harshman, K.,Tavtigian, S. V.,Stocker, E.,Day, R. S.,III, Johnson, B. E.,and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264:436-440, 1994.
16. Nobori, T.,Miura, K.,Wu, D. J.,Lois, A.,Takabayashi, K.,and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368:753-756, 1994.
17. Jen, J.,Harper, J. W.,Bigner, S. H.,Bigner, D. D.,Papadopoulos, N.,Markowtiz, S.,Willson, J. K.,Kinzler, K. W.,and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res.,54:6353-6358, 1994.
18. Okuda, T.,Shurtleff, S. A.,Valentine, M. B.,Raimondi, S. C.,Head, D. R.,Behm, F.,Curcio-Brint, A. M.,Liu, Q.,Pui, C-H.,Sherr, C. J.,Beach, D.,Look, T.,and Downing, J. R. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood, 85: 2321-2330, 1995.
19. Ogawa, S.,Hirano, N.,Sato, N.,Takahashi, T.,Hangaishi, A.,Tanaka, K.,Kurokawa, M.,Tanaka, T.,Mitani, K.,and Yazaki, Y. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood, 84:2431-2435, 1994.
20. INK4A) deletion in primary tumor cells of 163 leukemia patients. Blood, 85: 854, 1995.
21. Diccianni, M. B.,Batova, A.,Yu, J.,Xu, T.,Pullen, J.,Amylon, M.,Pollock, B.,and Yu, A. L. Gene status and clinical significance of p15, p16, and p18 in T-cell acute lymphoblastic leukemia. Leuk. Res.,in press, 1997.
22. Olopade, O. I.,Buchhagen, D. L.,Malik, K.,Sherman, J.,Nobori, T.,Bader, S.,Nau, M. M.,Gazdar, A. F.,Minna, J. D.,and Dizao, M. O. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res.,53:2410-2415, 1993.
23. Nobori, T.,Karras, J. G.,Della Ragione, F.,Waltz, T. A.,Chen, P. P.,and Carson, D. A. Absence of methylthioadenosine phosphorylase in human gliomas. Cancer Res.,51:3193-3197, 1991.
24. Yu, A. L.,Chen, J.,Diccianni, M. B.,Batova, A.,and Yu, J. Exploitation of frequent p16 deletion in the treatment of T-cell acute lymphoblastic leukemia. In:N. G. Abraham, S. Asano, G. Brittinger, and H-J. Schmoll (eds.), Molecular Biology of Hematopoiesis, p. 247. New York: Plenum Press, 1996.
25. Murthy, Y. K.,Thiemann, J. E.,Coronelli, C.,and Sensi, P. Alanosine, a new antiviral and antitumour agent isolated from a Streptomyces. Nature (Lond.), 211: 1198-1199, 1966.
26. Anadaraj, S. J.,Jayaram, H. N.,Cooney, D. A.,Tyagi, A. K.,Han, N.,Thomas, J. H.,Chitnis, M.,and Montgomery, J. A. Interaction of L-alanosine (NSC 153, 353) with enzymes metabolizing L-aspartic acid, L-glutamic acid and their amides. Biochem. Pharmacol.,29:227-245, 1980.
27. Gale, G. R.,and Schmidt, G. B. Mode of action of alanosine. Biochem. Pharmacol.,17:363-368, 1968.
28. Graff, J. C.,and Plagemann, P. G. Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate. Cancer Res.,36:1428-1440, 1976.
29. Metcalf, D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature (Lond.), 339:27-30, 1989.
30. Schwamborn, J. S.,Bergener, P.,Dreyer, N.,Schondorf, S.,and Riscoe, M. K. Methylthioadenosine phosphorylase "deficiency" of human hemopoietic progenitor cells. Acta Haematol. (Basel), 93:131, 1995.
31. Wolford, R. W.,Riscoe, M. K.,Johnson, L.,Ferro, A. J.,and Fitchen, J. H. Effect of 5′-methylthioadenosine (a naturally occurring nucleoside) on murine hematopoiesis. Exp. Hematol.,12:867-871, 1984.
32. Riscoe, M. K.,Schwambom, J.,Ferro, A. J.,Olson, K. D.,and Fitchen, J. H. Inhibition of growth but not differentiation of normal and leukemic myeloid cells by methylthioadenosine. Cancer Res.,47:3830-3834, 1987.
33. Borchardt, R. T. S-adenosyl-L-methionine-dependent macromolecule methyltransferases. Potential targets for the design of chemotherapeutic agents. J. Med. Chem.,23:347-357, 1980.
34. Pajula, R. L.,and Raina, A. Methylthioadenosine, a potent inhibitor of spermine synthase from bovine brain. FEBS Lett.,99: 343-345, 1979.
35. Hibasami, H.,Borchardt, R. T.,Chen, s. Y.,Coward, J. K.,and Pegg, A. E. Studies of inhibition of rat spermidine synthase and spermine synthase. Biochem. J.,187: 419-428, 1980.
36. Maber, P. A. Inhibition of the tyrosine kinase activity of the fibroblast growth factor receptor by the methyltransferase inhibitor 5′-methylthioadenosine. J. Biol. Chem.,268:4244-4249, 1993.
37. Ghoda, L. Y.,Saverese, T. M.,Dexter, D. L.,Parks, R. E.,Jr.,Trackman, P. C.,and Abeles, R. H. Characterization of a defect in the pathway for converting 5′-deoxy-5′methylthioadenosine to methionine in a subline of a cultured heterogeneous human colon carcinoma. J. Biol. Chem.,259: 6715-6719, 1984.